Understanding the impact of the vaginal microbiota on miscarriage: Are we there yet? DOI
Brandie D. Taylor, Lauren A. Wise

Paediatric and Perinatal Epidemiology, Journal Year: 2024, Volume and Issue: 38(7), P. 612 - 614

Published: Aug. 7, 2024

Miscarriage affects approximately 20% of recognised pregnancies1 and can cause severe psychological distress. A history miscarriage is associated with complications in subsequent pregnancies other adverse health outcomes.2 As many pregnancy outcomes, few established risk factors have been identified,3 preventative treatments are limited. In understanding the aetiological pathways that result idiopathic miscarriage, researchers may discover affordable accessible to intervene upon specific biological pathways. Factors disrupt maternal immune system promising targets for novel therapeutic interventions. The highly dynamic (not immunosuppressive as previously suggested) protects against ascending infections while maintaining a receptive environment ensures decidualisation, implantation placentation.4 Failures placentation linked miscarriage,5 emerging evidence indicates reproductive tract microbiota plays an essential role regulation modulation addition preventing overgrowth harmful bacteria.4 Scientific impact microbial communities on human has increased dramatically technological advances such 16S ribosomal RNA, DNA hybridisation next-generation sequencing, which overcome limitations culture-based methods. vaginal extensively studied. 'normal' determined by dominance Lactobacillus spp., controls proliferation bacterial species through production lactic acid, hydrogen peroxide bacteriocins.6 Variations stability some across menstrual cycles7 patient characteristics sexual behaviours pose challenge epidemiologic investigations. Studies suggest dysbiosis gynaecologic conditions, sexually transmitted infection acquisition, endometritis preterm delivery.8 However, association between inconsistent studies. Much this variation due differences study designs analyses, timing sampling use various molecular-based methods yield different information compositions (i.e. genus vs. strains). Of particular concern inability obtain samples before or near key processes implantation. Indeed, studies lack rationale their timing, because change markedly hormonal fluctuations, specimens sampled later gestation not represent present early pregnancy. issue Paediatric Perinatal Epidemiology, McClelland colleagues9 address prior authors nested investigation within Kenyan Microbiota Pre-term Birth (MPTB) study, preconception cohort participants who had recently discontinued contraception, measure at periconception (<28 days pregnancy) first trimester. Periconception was selected be close possible. Their measurement robust. It included evaluation relative abundance bacteria using n16s rRNA PCR informed quantitative (qPCR), method investigators used previously. results sequencing revealed abundances first-trimester were unadjusted models. primary analysis little greater concentrations Megasphaera hutchinsoni, Mageeibacillus indolicus, Mobiluncus mulieris Sneathia sanguinegens/vaginalis miscarriage. exploratory crude model found detection indolicus Mulieris miscarriage; warrants further investigation. Most epidemiological retrospective, confined pregnant prone outcome misclassification, left truncation recall selection biases. MPTB overcomes these its prospective design, enrollment, biomarker microbiome. Participants would unaware microbiome status future chances time enumeration, thereby reducing potential bias. Given exposures affect risk, better able ascertain aetiologically relevant periods. limitations. sample size only 45 cases 159 controls, reduced precision. difficulties obtaining periconceptional should considered. Lack access plagued Thus, small weighed well-designed study. While qPCR strength it including misinterpretation communities, limited measuring absolute quantities four bacteria, weakness appropriately acknowledged authors. trimester strength, from utilised. process decidualisation well placentation. also fluctuates changes, interesting know if there any changes periods into This target research. Vaginal more accessible, but data unclear regarding extent reflect upper tract. Potential mechanisms underlying fully understood, make hypotheses clear. One pathway ascension (including infections) genital tract, excessive inflammation pattern recognition receptor signalling. et al. determine Sexually measured, positive no those loss less likely Chlamydia trachomatis (4.4% 6.9%), Trichomonas vaginalis (0% 1.4%) vaginosis (33.3% 29.9%) than continue past 20 weeks gestation. On hand, endometrium fallopian tubes reported unique sterile thought.7 Mouse models endometrial receptivity mediated baseline type I interferon responses controlled local microbiota.4 Chen al.7 suggested cervical useful identify pathologies Others discordance microbiota, although low biomass contamination remain concerns investigations.8 Access tissues challenging almost impossible during Mechanistic improve our reproduction, could guide clinical animal vitro single-cell systems do experience. growing organ-on-chip replicate female promising, incorporating remains challenge.10 summary, did find strong findings discourage research area. highlights challenges area identifies areas Brandie DePaoli Taylor professor perinatal epidemiologist University Texas Medical Branch, Galveston, TX. Her examines how innate immunity success. Dr. collaborates closely basic scientists incorporate mechanistic investigations infection, immunology complications. Lauren A. Wise Boston School Public Health. She Principal Investigator Pregnancy Study Online (PRESTO), North American couples. focuses environmental, dietary lifestyle determinants serves associate editor Epidemiology. BDT took lead drafting commentary. Both contributed substantially conception work revised critically intellectual content. approve final version published agree accountable all aspects work. None. supported grants National Institutes Health (R01AI141501-01A1 R01AI143653-01A1). (R01HD086742, R01HD105863, R01ES029951 R01HD115096) Science Foundation (NSF 1914792). paid consultant AbbVie, Inc. Gates receives in-kind donations collection (PRESTO) Swiss Precision Diagnostics (home tests) Kindara.com (fertility-tracking apps). There involved

Language: Английский

Vaginal Microbiome and Fertility DOI

Ida Behrendt-Møller,

Henriette Svarre Nielsen, Kilian Vomstein

et al.

Elsevier eBooks, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

Language: Английский

Citations

0

Microbiota and Recurrent Pregnancy Loss (RPL); More than a Simple Connection DOI Creative Commons
Jenny Garmendia, Claudia Valentina De Sanctis, Marián Hajdúch

et al.

Microorganisms, Journal Year: 2024, Volume and Issue: 12(8), P. 1641 - 1641

Published: Aug. 10, 2024

Recurrent Pregnancy Loss (RPL) affects 1–2% of women, and its triggering factors are unclear. Several studies have shown that the vaginal, endometrial, gut microbiota may play a role in RPL. A decrease quantity Lactobacillus crispatus local has been associated with an increase (vaginal endometrial) inflammatory response immune cell activation leads to pregnancy loss. The be triggered by gram-negative bacteria, lipopolysaccharides (LPS), viral infections, mycosis, or atypia (tumor growth). Bacterial structures metabolites produced could involved modulation responsible for molecular mimicry. Gut metabolic products amount circulating pro-inflammatory lymphocytes, which, turn, will migrate into vaginal endometrial tissues. Local Th1 Th17 subpopulations Treg tolerogenic NK cells accountable modulate response, increasing success. Analyzing necessary characterize some RPL patients. Although oral supplementation probiotics not modify microbiota, it benefit transplantation vagina enhance required achieve normal pregnancy. effect hormone stimulation progesterone maintain early on adequately studied, more research is needed this area. Well-designed clinical trials ascertain

Language: Английский

Citations

2

Evaluating risk factors in recurrent pregnancy loss: A prospective cohort study and its impact on live birth outcomes DOI Creative Commons

Josefine Reinhardt Nielsen,

Astrid Marie Kolte, Sofie Bliddal

et al.

Journal of Reproductive Immunology, Journal Year: 2024, Volume and Issue: 165, P. 104297 - 104297

Published: July 14, 2024

Recurrent pregnancy loss (RPL) affects 1–2 % of all couples trying to conceive and is a challenging heterogeneous condition. This study aimed evaluate the prevalence impact various risk factors in patients suffering from RPL. We performed prospective cohort including at tertiary RPL Unit Capital Region Denmark between 1st January 2000 2023. The main outcome was first after referral whether ongoing least 22nd gestational week. A total 2555 were included study, out whom 1892 achieved Unit. resulted 1103 live births (58.3 %) 718 losses (37.9 %). Maternal age, BMI, smoking status number prior negatively correlated with likelihood achieving pregnancy. Furthermore, maternal losses, antiphospholipid syndrome (APS) uterine malformations associated reduced birth rates. Patients secondary had higher rate compared those primary RPL, APS treated low-molecular-weight heparin (LMWH) demonstrated significantly increased untreated patients. These findings suggest that certain following which can be used patient guidance.

Language: Английский

Citations

1

Integrated functional analysis of endometrial transcriptome, microbiome, and immune cell profiling is needed to dissect mechanisms of uterine pathologies and implantation failure DOI Creative Commons
Ganesh Acharya

Acta Obstetricia Et Gynecologica Scandinavica, Journal Year: 2024, Volume and Issue: 103(7), P. 1236 - 1237

Published: June 12, 2024

Human endometrium is a unique dynamic tissue that renewed regularly in reproductive age women by undergoing regular cyclical changes which involve shedding, regeneration, proliferation, and remodeling response to hormones. Thus, it not surprising substantial occur gene expression, composition of microbiota, immune cell profile the tract tissues including during physiological transitions, such as menstrual cycle, pregnancy, aging, well pathological conditions. Our ability investigate transcriptome, microbiome, potential molecular functions differentially expressed genes microbiota are involved, their interaction with system has improved substantially recent years due development high-throughput technologies, bioinformatics, artificial intelligence. Multiomics approach been widely applied biomedical research. However, scientific breakthroughs clinical significance have scarce field gynecology medicine. An article Bui et al.1 published this issue AOGS investigated association endometrial transcriptome mid-luteal phase biopsies embryo implantation outcomes. Results were compared between failure success groups short-term (after second fresh IVF/ICSI cycle) 33 ongoing pregnancy vs. 52 no long-term (including all frozen cycles within 12 months) 23 infertile livebirth after ≤3 embryos transferred ≥3 good quality (i.e., recurrent group). The screened for aneuploidy preimplantation genetic testing study. authors found clearly distinct was associated either or women. Similar findings differences expression taken proliferative from having (n = 9) following transfer performed same cycle previously reported.2 Plethora studies on transcriptomics, single-cell transcriptomic atlas human improving our understanding processes.3 recently systematic review revealed inconsistently reported concluded "the large majority do advance identification underlying biological mechanisms."4 Furthermore, receptivity affected only its but also interactions cells tract. Endometrial microbial can be changed exogenous hormones, commonly used treatment, modulate tolerance periconceptional period pregnancy.5-7 complex interplay host confounding effect other intrinsic extrinsic factors often ignored. Endometriosis adenomyosis common gynecological disorders considerable morbidity characterized ectopic growth endometrium. etiology unknown, both conditions appear share similar pathophysiology,8 dysregulation/dysfunction conditions.8, 9 Another study journal Valdés-Bango al.10 evaluated vagina, endometrium, gut individuals 38) without 46) adenomyosis. main reduced diversity patients adenomyosis, significant vaginal controls, profiles among internal external Although these suggest mechanisms elucidated. uterine microenvironment maintained balance coordinated system. Therefore, an integrated functional investigating aspects required address pathologies failure.

Language: Английский

Citations

0

Understanding the impact of the vaginal microbiota on miscarriage: Are we there yet? DOI
Brandie D. Taylor, Lauren A. Wise

Paediatric and Perinatal Epidemiology, Journal Year: 2024, Volume and Issue: 38(7), P. 612 - 614

Published: Aug. 7, 2024

Miscarriage affects approximately 20% of recognised pregnancies1 and can cause severe psychological distress. A history miscarriage is associated with complications in subsequent pregnancies other adverse health outcomes.2 As many pregnancy outcomes, few established risk factors have been identified,3 preventative treatments are limited. In understanding the aetiological pathways that result idiopathic miscarriage, researchers may discover affordable accessible to intervene upon specific biological pathways. Factors disrupt maternal immune system promising targets for novel therapeutic interventions. The highly dynamic (not immunosuppressive as previously suggested) protects against ascending infections while maintaining a receptive environment ensures decidualisation, implantation placentation.4 Failures placentation linked miscarriage,5 emerging evidence indicates reproductive tract microbiota plays an essential role regulation modulation addition preventing overgrowth harmful bacteria.4 Scientific impact microbial communities on human has increased dramatically technological advances such 16S ribosomal RNA, DNA hybridisation next-generation sequencing, which overcome limitations culture-based methods. vaginal extensively studied. 'normal' determined by dominance Lactobacillus spp., controls proliferation bacterial species through production lactic acid, hydrogen peroxide bacteriocins.6 Variations stability some across menstrual cycles7 patient characteristics sexual behaviours pose challenge epidemiologic investigations. Studies suggest dysbiosis gynaecologic conditions, sexually transmitted infection acquisition, endometritis preterm delivery.8 However, association between inconsistent studies. Much this variation due differences study designs analyses, timing sampling use various molecular-based methods yield different information compositions (i.e. genus vs. strains). Of particular concern inability obtain samples before or near key processes implantation. Indeed, studies lack rationale their timing, because change markedly hormonal fluctuations, specimens sampled later gestation not represent present early pregnancy. issue Paediatric Perinatal Epidemiology, McClelland colleagues9 address prior authors nested investigation within Kenyan Microbiota Pre-term Birth (MPTB) study, preconception cohort participants who had recently discontinued contraception, measure at periconception (<28 days pregnancy) first trimester. Periconception was selected be close possible. Their measurement robust. It included evaluation relative abundance bacteria using n16s rRNA PCR informed quantitative (qPCR), method investigators used previously. results sequencing revealed abundances first-trimester were unadjusted models. primary analysis little greater concentrations Megasphaera hutchinsoni, Mageeibacillus indolicus, Mobiluncus mulieris Sneathia sanguinegens/vaginalis miscarriage. exploratory crude model found detection indolicus Mulieris miscarriage; warrants further investigation. Most epidemiological retrospective, confined pregnant prone outcome misclassification, left truncation recall selection biases. MPTB overcomes these its prospective design, enrollment, biomarker microbiome. Participants would unaware microbiome status future chances time enumeration, thereby reducing potential bias. Given exposures affect risk, better able ascertain aetiologically relevant periods. limitations. sample size only 45 cases 159 controls, reduced precision. difficulties obtaining periconceptional should considered. Lack access plagued Thus, small weighed well-designed study. While qPCR strength it including misinterpretation communities, limited measuring absolute quantities four bacteria, weakness appropriately acknowledged authors. trimester strength, from utilised. process decidualisation well placentation. also fluctuates changes, interesting know if there any changes periods into This target research. Vaginal more accessible, but data unclear regarding extent reflect upper tract. Potential mechanisms underlying fully understood, make hypotheses clear. One pathway ascension (including infections) genital tract, excessive inflammation pattern recognition receptor signalling. et al. determine Sexually measured, positive no those loss less likely Chlamydia trachomatis (4.4% 6.9%), Trichomonas vaginalis (0% 1.4%) vaginosis (33.3% 29.9%) than continue past 20 weeks gestation. On hand, endometrium fallopian tubes reported unique sterile thought.7 Mouse models endometrial receptivity mediated baseline type I interferon responses controlled local microbiota.4 Chen al.7 suggested cervical useful identify pathologies Others discordance microbiota, although low biomass contamination remain concerns investigations.8 Access tissues challenging almost impossible during Mechanistic improve our reproduction, could guide clinical animal vitro single-cell systems do experience. growing organ-on-chip replicate female promising, incorporating remains challenge.10 summary, did find strong findings discourage research area. highlights challenges area identifies areas Brandie DePaoli Taylor professor perinatal epidemiologist University Texas Medical Branch, Galveston, TX. Her examines how innate immunity success. Dr. collaborates closely basic scientists incorporate mechanistic investigations infection, immunology complications. Lauren A. Wise Boston School Public Health. She Principal Investigator Pregnancy Study Online (PRESTO), North American couples. focuses environmental, dietary lifestyle determinants serves associate editor Epidemiology. BDT took lead drafting commentary. Both contributed substantially conception work revised critically intellectual content. approve final version published agree accountable all aspects work. None. supported grants National Institutes Health (R01AI141501-01A1 R01AI143653-01A1). (R01HD086742, R01HD105863, R01ES029951 R01HD115096) Science Foundation (NSF 1914792). paid consultant AbbVie, Inc. Gates receives in-kind donations collection (PRESTO) Swiss Precision Diagnostics (home tests) Kindara.com (fertility-tracking apps). There involved

Language: Английский

Citations

0